188 related articles for article (PubMed ID: 8281471)
21. Animal models for radiolabeled monoclonal antibodies in cancer research.
Aas M; Fjeld JG
Acta Oncol; 1993; 32(7-8):819-24. PubMed ID: 8305231
[TBL] [Abstract][Full Text] [Related]
22. Current status of monoclonal antibodies for imaging and therapy of prostate cancer.
Bander NH
Semin Oncol; 1994 Oct; 21(5):607-12. PubMed ID: 7939751
[TBL] [Abstract][Full Text] [Related]
23. Targeting cancer with radiolabeled antibodies.
Goldenberg DM; Larson SM; Reisfeld RA; Schlom J
Immunol Today; 1995 Jun; 16(6):261-4. PubMed ID: 7662094
[No Abstract] [Full Text] [Related]
24. [New therapeutic approach to pancreatic cancer by monoclonal antibodies].
Sawada T; Chung YS; Sowa M
Gan To Kagaku Ryoho; 1996 Oct; 23(12):1654-6. PubMed ID: 8886037
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibody therapy for cancer.
von Mehren M; Adams GP; Weiner LM
Annu Rev Med; 2003; 54():343-69. PubMed ID: 12525678
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunodetection and radioimmunotherapy of breast cancer.
Riva P; Franceschi G; Gentile R; Riva N; Casi M
Tumori; 1997; 83(2):552-7. PubMed ID: 9226019
[No Abstract] [Full Text] [Related]
27. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma patients.
Coiffier B
Haematologica; 1999 Jun; 84 Suppl EHA-4():14-8. PubMed ID: 10907457
[No Abstract] [Full Text] [Related]
28. Monoclonal antibodies in cancer detection and therapy.
Goldenberg DM
Am J Med; 1993 Mar; 94(3):297-312. PubMed ID: 8452154
[TBL] [Abstract][Full Text] [Related]
29. Radiolabeled monoclonal antibodies in diagnosis and therapy of cancer. Summary and perspectives.
Britton KE
Acta Oncol; 1996; 35(3):385-90. PubMed ID: 8679271
[TBL] [Abstract][Full Text] [Related]
30. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy.
Goldenberg DM
Semin Nucl Med; 1989 Oct; 19(4):332-9. PubMed ID: 2678484
[TBL] [Abstract][Full Text] [Related]
31. A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
Wong JY; Chu DZ; Williams LE; Liu A; Zhan J; Yamauchi DM; Wilczynski S; Wu AM; Yazaki PJ; Shively JE; Leong L; Raubitschek AA
Cancer Biother Radiopharm; 2006 Apr; 21(2):88-100. PubMed ID: 16706629
[TBL] [Abstract][Full Text] [Related]
32. Advances in monoclonal antibody therapy of cancer.
LoBuglio AF; Saleh MN
Am J Med Sci; 1992 Sep; 304(3):214-24. PubMed ID: 1476160
[TBL] [Abstract][Full Text] [Related]
33. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibodies: the promise and the reality.
Coons T
Radiol Technol; 1995; 67(1):39-60; quiz 61-4. PubMed ID: 7491408
[TBL] [Abstract][Full Text] [Related]
35. Tumor site-directed therapy for hepatocellular carcinoma using monoclonal antibodies against hepatoma-associated antigens.
Shouval D; Adler R
Prog Liver Dis; 1993; 11():251-67. PubMed ID: 8272514
[No Abstract] [Full Text] [Related]
36. Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice.
Inui A; Chung YS; Sawada T; Kondo Y; Ho JJ; Kim YS; Sowa M
Jpn J Cancer Res; 1996 Sep; 87(9):977-84. PubMed ID: 8878462
[TBL] [Abstract][Full Text] [Related]
37. Targeted antibodies in the treatment of lymphomas.
Falini B; Terenzi A; Liso A; Flenghi L; Solinas A; Pasqualucci L
Cancer Surv; 1997; 30():295-309. PubMed ID: 9547998
[TBL] [Abstract][Full Text] [Related]
38. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
[TBL] [Abstract][Full Text] [Related]
39. New insights into the pretargeting approach to image and treat tumours.
Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
[TBL] [Abstract][Full Text] [Related]
40. Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer.
Syrigos KN; Deonarian DP; Epenetos AA
Hybridoma; 1999 Jun; 18(3):219-24. PubMed ID: 10475235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
